This Article Full Text Full Text (PDF) All Versions of this Article: 109/8/1029    most recent 01.CIR.0000115519.03688.A2v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rutanen, J. Articles by Ylä-Herttuala, S. Search for Related Content PubMed PubMed Citation Articles by Rutanen, J. Articles by Ylä-Herttuala, S. Related Collections Angiogenesis Growth factors/cytokines Echocardiography Gene therapy Mechanism of atherosclerosis/growth factors

(Circulation. 2004;109:1029-1035.)
© 2004 American Heart Association, Inc.

Basic Science Reports

Adenoviral Catheter-Mediated Intramyocardial Gene Transfer Using the Mature Form of Vascular Endothelial Growth Factor-D Induces Transmural Angiogenesis in Porcine Heart

Juha Rutanen, MD^*; Tuomas T. Rissanen, MD, PhD^*; Johanna E. Markkanen, MD; Marcin Gruchala, MD; Päivi Silvennoinen, MD; Antti Kivelä, MD; Antti Hedman, MD, PhD; Marja Hedman, MD, PhD; Tommi Heikura, MSc; Maija-Riitta Ordén, MD, PhD; Steven A. Stacker, PhD; Marc G. Achen, PhD; Juha Hartikainen, MD, PhD; Seppo Ylä-Herttuala, MD, PhD

From the Department of Molecular Medicine, A.I. Virtanen Institute, Kuopio University, Finland (J.R., T.T.R., J.E.M., M.G., P.S., T.H., M.-R.O., S.Y.-H.); the Departments of Medicine (A.K., A.H., M.H., J.H., S.Y.-H.) and Obstetrics and Gynecology (M.-R.O.) and the Gene Therapy Unit (S.Y.-H.), Kuopio University Hospital, Kuopio, Finland; and the Ludwig Institute for Cancer Research, Royal Melbourne Hospital, Victoria, Australia (S.A.S., M.G.A.).

Correspondence to Seppo Ylä-Herttuala, MD, PhD, FESC, A. I. Virtanen Institute, Kuopio University, PO Box 1627, FIN-70211 Kuopio, Finland. E-mail seppo.ylaherttuala{at}uku.fi

Received May 13, 2003; de novo received August 28, 2003; revision received October 28, 2003; accepted October 31, 2003.

Background— It is unclear what is the most efficient vector and growth factor for induction of therapeutic vascular growth in the heart. Furthermore, the histological nature of angiogenesis and potential side effects caused by different vascular endothelial growth factors (VEGFs) in myocardium have not been documented.

Methods and Results— Adenoviruses (Ad) at 2 doses (2x10¹¹ and 2x10¹² viral particles) or naked plasmids (1 mg) encoding LacZ control, VEGF-A₁₆₅, or the mature, soluble form of VEGF-D (VEGF-D^NC) were injected intramyocardially with the NOGA catheter system into domestic pigs. AdVEGF-D^NC gene transfer (GT) induced a dose-dependent myocardial protein production, as measured by ELISA, resulting in an efficient angiogenic effect 6 days after the injections. Also, AdVEGF-A₁₆₅ produced high gene transfer efficacy, as demonstrated with immunohistochemistry, leading to prominent angiogenesis effects. Despite the catheter-mediated approach, angiogenesis induced by both AdVEGFs was transmural, with maximal effects in the epicardium. Histologically, strongly enlarged -smooth muscle actin–positive microvessels involving abundant cell proliferation were found in the transduced regions, whereas microvessel density did not change. Myocardial contrast echocardiography and microspheres showed marked increases in perfusion in the transduced areas. VEGF-D^NC but not matrix-bound VEGF-A₁₆₅ was detected in plasma after adenoviral GT. A modified Miles assay demonstrated myocardial edema resulting in pericardial effusion with the higher AdVEGF doses. All effects returned to baseline by 3 weeks. Naked plasmid–mediated GT did not induce detectable protein production or vascular effects.

Conclusions— Like AdVEGF-A₁₆₅, AdVEGF-D^NC GT using the NOGA system produces efficient transmural angiogenesis and increases myocardial perfusion. AdVEGF-D^NC could be useful for the induction of therapeutic vascular growth in the heart.

Key Words: angiogenesis • echocardiography • gene therapy • perfusion • regional blood flow

This article has been cited by other articles:

				P. I. Toivanen, T. Nieminen, L. Viitanen, A. Alitalo, M. Roschier, S. Jauhiainen, J. E. Markkanen, O. H. Laitinen, T. T. Airenne, T. A. Salminen, et al. Novel Vascular Endothelial Growth Factor D Variants with Increased Biological Activity J. Biol. Chem., June 5, 2009; 284(23): 16037 - 16048. [Abstract] [Full Text] [PDF]

				A. Anisimov, A. Alitalo, P. Korpisalo, J. Soronen, S. Kaijalainen, V.-M. Leppanen, M. Jeltsch, S. Yla-Herttuala, and K. Alitalo Activated Forms of VEGF-C and VEGF-D Provide Improved Vascular Function in Skeletal Muscle Circ. Res., June 5, 2009; 104(11): 1302 - 1312. [Abstract] [Full Text] [PDF]

				A.-M. Karkkainen, A. Kotimaa, J. Huusko, I. Kholova, S. E. Heinonen, A. Stefanska, M. H. Dijkstra, H. Purhonen, E. Hamalainen, P. I. Makinen, et al. Vascular endothelial growth factor-D transgenic mice show enhanced blood capillary density, improved postischemic muscle regeneration, and increased susceptibility to tumor formation Blood, April 30, 2009; 113(18): 4468 - 4475. [Abstract] [Full Text] [PDF]

				J. E. Lahteenvuo, M. T. Lahteenvuo, A. Kivela, C. Rosenlew, A. Falkevall, J. Klar, T. Heikura, T. T. Rissanen, E. Vahakangas, P. Korpisalo, et al. Vascular Endothelial Growth Factor-B Induces Myocardium-Specific Angiogenesis and Arteriogenesis via Vascular Endothelial Growth Factor Receptor-1- and Neuropilin Receptor-1-Dependent Mechanisms Circulation, February 17, 2009; 119(6): 845 - 856. [Abstract] [Full Text] [PDF]

				P. Korpisalo, T. T. Rissanen, T. Bengtsson, T. Liimatainen, S. Laidinen, H. Karvinen, J. E. Markkanen, O. H. Grohn, and S. Yla-Herttuala Therapeutic angiogenesis with placental growth factor improves exercise tolerance of ischaemic rabbit hindlimbs Cardiovasc Res, November 1, 2008; 80(2): 263 - 270. [Abstract] [Full Text] [PDF]

				A.-L. Levonen, E. Vahakangas, J. K. Koponen, and S. Yla-Herttuala Antioxidant Gene Therapy for Cardiovascular Disease: Current Status and Future Perspectives Circulation, April 22, 2008; 117(16): 2142 - 2150. [Abstract] [Full Text] [PDF]

				H. Viita, J. Markkanen, E. Eriksson, M. Nurminen, K. Kinnunen, M. Babu, T. Heikura, S. Turpeinen, S. Laidinen, T. Takalo, et al. 15-Lipoxygenase-1 Prevents Vascular Endothelial Growth Factor A- and Placental Growth Factor-Induced Angiogenic Effects in Rabbit Skeletal Muscles via Reduction in Growth Factor mRNA Levels, NO Bioactivity, and Downregulation of VEGF Receptor 2 Expression Circ. Res., February 1, 2008; 102(2): 177 - 184. [Abstract] [Full Text] [PDF]

				A R Lyon, M Sato, R J Hajjar, R J Samulski, and S E Harding Gene therapy: targeting the myocardium Heart, January 1, 2008; 94(1): 89 - 99. [Abstract] [Full Text] [PDF]

				A. Jacquier, C. B. Higgins, A. J. Martin, L. Do, D. Saloner, and M. Saeed Injection of Adeno-associated Viral Vector Encoding Vascular Endothelial Growth Factor Gene in Infarcted Swine Myocardium: MR Measurements of Left Ventricular Function and Strain Radiology, October 1, 2007; 245(1): 196 - 205. [Abstract] [Full Text] [PDF]

				T. Okazaki, S. Ebihara, M. Asada, S. Yamanda, Y. Saijo, Y. Shiraishi, T. Ebihara, K. Niu, H. Mei, H. Arai, et al. Macrophage Colony-Stimulating Factor Improves Cardiac Function after Ischemic Injury by Inducing Vascular Endothelial Growth Factor Production and Survival of Cardiomyocytes Am. J. Pathol., October 1, 2007; 171(4): 1093 - 1103. [Abstract] [Full Text] [PDF]

				L. Kopfstein, T. Veikkola, V. G. Djonov, V. Baeriswyl, T. Schomber, K. Strittmatter, S. A. Stacker, M. G. Achen, K. Alitalo, and G. Christofori Distinct Roles of Vascular Endothelial Growth Factor-D in Lymphangiogenesis and Metastasis Am. J. Pathol., April 1, 2007; 170(4): 1348 - 1361. [Abstract] [Full Text] [PDF]

				S. Yla-Herttuala, T. T. Rissanen, I. Vajanto, and J. Hartikainen Vascular Endothelial Growth Factors: Biology and Current Status of Clinical Applications in Cardiovascular Medicine J. Am. Coll. Cardiol., March 13, 2007; 49(10): 1015 - 1026. [Abstract] [Full Text] [PDF]

				O. J. Muller, H. A. Katus, and R. Bekeredjian Targeting the heart with gene therapy-optimized gene delivery methods Cardiovasc Res, February 1, 2007; 73(3): 453 - 462. [Abstract] [Full Text] [PDF]

				X. Hao, A. Mansson-Broberg, K.-H. Grinnemo, A. J. Siddiqui, G. Dellgren, L. A. Brodin, and C. Sylven Myocardial angiogenesis after plasmid or adenoviral VEGF-A165 gene transfer in rat myocardial infarction model Cardiovasc Res, February 1, 2007; 73(3): 481 - 487. [Abstract] [Full Text] [PDF]

				R. de Silva, L. F. Gutierrez, A. N. Raval, E. R. McVeigh, C. Ozturk, and R. J. Lederman X-Ray Fused With Magnetic Resonance Imaging (XFM) to Target Endomyocardial Injections: Validation in a Swine Model of Myocardial Infarction Circulation, November 28, 2006; 114(22): 2342 - 2350. [Abstract] [Full Text] [PDF]

				O. Tenhunen, Y. Soini, M. Ilves, J. Rysa, J. Tuukkanen, R. Serpi, H. Pennanen, H. Ruskoaho, and H. Leskinen p38 Kinase rescues failing myocardium after myocardial infarction: evidence for angiogenic and anti-apoptotic mechanisms FASEB J, September 1, 2006; 20(11): 1907 - 1909. [Abstract] [Full Text] [PDF]

				T. T. Rissanen, P. Korpisalo, J. E. Markkanen, T. Liimatainen, M.-R. Orden, I. Kholova, A. de Goede, T. Heikura, O. H. Grohn, and S. Yla-Herttuala Blood Flow Remodels Growing Vasculature During Vascular Endothelial Growth Factor Gene Therapy and Determines Between Capillary Arterialization and Sprouting Angiogenesis Circulation, December 20, 2005; 112(25): 3937 - 3946. [Abstract] [Full Text] [PDF]

				T. Kofidis, J. L. de Bruin, T. Yamane, M. Tanaka, D. R. Lebl, R.-J. Swijnenburg, I. L. Weissman, and R. C. Robbins Stimulation of Paracrine Pathways With Growth Factors Enhances Embryonic Stem Cell Engraftment and Host-Specific Differentiation in the Heart After Ischemic Myocardial Injury Circulation, May 17, 2005; 111(19): 2486 - 2493. [Abstract] [Full Text] [PDF]

				M. E. Baldwin, M. M. Halford, S. Roufail, R. A. Williams, M. L. Hibbs, D. Grail, H. Kubo, S. A. Stacker, and M. G. Achen Vascular Endothelial Growth Factor D Is Dispensable for Development of the Lymphatic System Mol. Cell. Biol., March 15, 2005; 25(6): 2441 - 2449. [Abstract] [Full Text] [PDF]

				J. E. Markkanen, T. T. Rissanen, A. Kivela, and S. Yla-Herttuala Growth factor-induced therapeutic angiogenesis and arteriogenesis in the heart-gene therapy Cardiovasc Res, February 15, 2005; 65(3): 656 - 664. [Abstract] [Full Text] [PDF]

				H. Jia, A. Bagherzadeh, R. Bicknell, M. R. Duchen, D. Liu, and I. Zachary Vascular Endothelial Growth Factor (VEGF)-D and VEGF-A Differentially Regulate KDR-mediated Signaling and Biological Function in Vascular Endothelial Cells J. Biol. Chem., August 20, 2004; 279(34): 36148 - 36157. [Abstract] [Full Text] [PDF]